SDEV — Stablecoin Development Corp
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1389545 ·
Last close
$1.31
Market Cap
$35.52M
52W High
$2.13
52W Low
$1.11
ADV30
239,968
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,463,000 | — | -385,000 | 552,403,000 | 179,743,000 | 18,405,000 | 40,918,000 |
| Dec 2025 | -521,000 | — | -1,824,000 | -26,596,000 | 9,035,000 | 7,958,000 | 640,850,000 |
| Sep 2025 | 521,000 | 42,000 | -1,169,000 | -1,293,000 | 3,487,000 | 2,309,000 | 2,378,000 |
| Jun 2025 | 0 | — | -1,891,000 | -1,922,000 | 6,911,000 | 5,344,000 | 2,666,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,430,000
Investing CF
$0
Financing CF
$4,615,000
CapEx
$-4,000
Dividends Paid
$-2,000
Buybacks
—
EPS Diluted TTM
$-5.25
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-819,054,000
Inventory
$467,000
Receivables
$374,000
ST Investments
—
EBIT TTM
$-32,945,000
Pretax Income TTM
$-33,222,000
Interest Exp TTM
$277,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$25,137,000
EBITDA
—
Free Cash Flow
$11,539,500
Enterprise Value
$20,465,060
Total Cash
$18,405,000
Total Debt
$637,000
Shares Out
27,115,646
Trailing EPS
$-22.03
Book Value
$-0.92
ROE
720.7%
ROA
11.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -7,585,000 | -630,780,000 | 9,035,000 | 640,850,000 | — | -8,430,000 |
| Dec 2024 | 0 | -7,379,000 | -7,223,000 | 3,423,000 | 3,552,000 | — | -7,497,000 |
| Dec 2023 | 10,455,000 | -4,102,000 | -9,640,000 | 9,034,000 | 5,720,000 | — | -4,261,000 |
| Dec 2022 | 14,404,000 | -7,680,000 | -10,608,000 | 16,399,000 | 5,845,000 | — | -6,654,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LITS | Lite Strategy, Inc. | $35.73M | $1.05 | — |
| DARE | Dare Bioscience, Inc. | $35.05M | $2.34 | — |
| RADX | Radiopharm Theranostics Ltd | $36.34M | $4.61 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | $36.39M | $1.16 | — |
| GRCE | Grace Therapeutics, Inc. | $36.52M | $2.36 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.